Serial Number 88829938
Registration 7012841
700

Registration Progress

Application Filed
Mar 11, 2020
Under Examination
Sep 8, 2020
Approved for Publication
Jul 14, 2020
Published for Opposition
Jul 14, 2020
Registered
Mar 28, 2023

Trademark Image

Basic Information

Serial Number
88829938
Registration Number
7012841
Filing Date
March 11, 2020
Registration Date
March 28, 2023
Published for Opposition
July 14, 2020
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 28, 2023
Registration
Registered
Classes
044

Rights Holder

Sarepta Therapeutics, Inc.

03
Address
215 First Street
Cambridge, MA 02142

Ownership History

Sarepta Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sarepta Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Sarepta Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Paul C. Llewellyn

USPTO Deadlines

Next Deadline
1330 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-03-28)
Due Date
March 28, 2029
Grace Period Ends
September 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

40 events
Date Code Type Description Documents
Mar 28, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 28, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 23, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 22, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 18, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 17, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 24, 2023 IUAF S USE AMENDMENT FILED Loading...
Jan 24, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 7, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 7, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 3, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 3, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 3, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 8, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 8, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 8, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 8, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 8, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 14, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 14, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 24, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 9, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 9, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 9, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 9, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 9, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 3, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 3, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 3, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 3, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 18, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 17, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 14, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options; Provision of health care services, namely, providing information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options
First Use Anywhere: Oct 6, 2013
First Use in Commerce: Oct 6, 2013

Additional Information

Design Mark
The mark consists of an abstract representation of the DNA double helix structure in maroon and gold.
Color Claim
The color(s) maroon and gold is/are claimed as a feature of the mark.

Classification

International Classes
044